• Rheumatoid Arthritis 83 global 1 0.75 9 0.75 2 0.75 0.75 Roundtable 0 1
  An Expert Discussion on JAK Inhibitors and the Management of Inflammatory Joint Diseases
  Rheumatology2023-09-24 20:00:00
  Are you up to date on the latest evidence regarding the use of Janus kinase (JAK) inhibitors in inflammatory joint diseases?
  
  0.75ABIM MOC 0.75CME/CE 45MIN

  
  Save
• Osteoarthritis 107 global 1 0.5 9 0.5 0.5 Roundtable 0 1
  Current Guidelines for Osteoarthritis: What Are the Practice Implications for Oral NSAIDs?
  Family Medicine/Primary Care2023-07-20 20:00:00
  Osteoarthritis (OA) pain can limit function, mobility, and quality of life. Join our experts to learn how to reduce OA burden with appropriate pain management and treatment.
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Spondylitis, Spondylosis, Kyphosis 118 us 1 0.25 9 0.25 0.25 Roundtable 0 1
  Raising the Bar: Optimizing Outcomes in Spondyloarthritis
  Rheumatology2023-06-29 20:00:00
  What are appropriate treatment goals to achieve disease suppression in your patients with spondyloarthritis?
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Psoriasis 29 global 1 0.75 9 0.75 2 0.75 0.75 Roundtable 0 1
  The Psoriasis Clinic: Maximizing Topical Treatment Options
  Dermatology2023-03-09 19:00:00
  Are you up to date on the latest topical therapies for psoriasis?
  
  0.75ABIM MOC 0.75CME/CE 45MIN

  
  Save
• Psoriasis 29 global 1 0.25 0.25 Clinical Case 0 1
  Full-Court Press: Talking to Patients About Psoriasis in Sensitive Areas
  Dermatology2023-03-09 19:00:00
  Did you know that almost half of patients with psoriasis lesions in their genital area do not discuss their symptoms with their clinician?
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Spondylitis, Spondylosis, Kyphosis 118 us 1 0.75 9 0.75 0.75 Roundtable 0 1
  Optimizing Outcomes for Spondyloarthritis: Focus on Interleukin-23/-17 Inhibitors
  Rheumatology2023-03-08 19:00:00
  What's new in treatments for spondyloarthritis? Learn more about the rationale for novel therapies and the latest data.
  
  0.75ABIM MOC 0.75CME/CE 45MIN

  
  Save
• Rheumatoid Arthritis 83 global 1 0.75 9 0.75 2 0.75 0.75 Roundtable 0 1
  An Expert Discussion on JAK Inhibitors and the Management of Inflammatory Joint Diseases
  Rheumatology2023-09-24 20:00:00
  Are you up to date on the latest evidence regarding the use of Janus kinase (JAK) inhibitors in inflammatory joint diseases?
  
  0.75ABIM MOC 0.75CME/CE 45MIN

  
  Save
• Advanced and Metastatic Breast Cancer 846 global 1 1.0 9 1.0 1.0 Clinical Review 0 2
  Clinical Overview of Oral Selective Estrogen Receptor Degraders
  Hematology-Oncology2023-09-20 00:00:00
  Do you know how to incorporate oral selective estrogen receptor degraders (SERDs) in patients with hormone receptor (HR)-positive advanced breast cancer?
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• COVID-19 6012524 global 1 0.25 9 0.25 2 0.25 3 0.25 8 0.25 0.25 Clinical Brief 0 2
  How Do Postacute Effects of COVID Compare With Other Acute Illnesses?
  Infectious Diseases2023-09-08 00:00:00
  A new study compares the outcomes of COVID-19, influenza, and sepsis at 1 year.
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Myelodysplastic Syndrome 1557 global 1 1.0 9 1.0 1.0 Journal Article 0 1
  Spectrum of Clonal Hematopoiesis in VEXAS Syndrome
  Hematology-Oncology2023-07-20 20:00:00
  UBA1^mut cells are the main cause of systemic inflammation/marrow failure in VEXAS, a new molecularly defined somatic entity linked to myelodysplastic syndrome (MDS).
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Osteoarthritis 107 global 1 0.5 9 0.5 0.5 Roundtable 0 1
  Current Guidelines for Osteoarthritis: What Are the Practice Implications for Oral NSAIDs?
  Family Medicine/Primary Care2023-07-20 20:00:00
  Osteoarthritis (OA) pain can limit function, mobility, and quality of life. Join our experts to learn how to reduce OA burden with appropriate pain management and treatment.
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Spondylitis, Spondylosis, Kyphosis 118 us 1 0.25 9 0.25 0.25 Roundtable 0 1
  Raising the Bar: Optimizing Outcomes in Spondyloarthritis
  Rheumatology2023-06-29 20:00:00
  What are appropriate treatment goals to achieve disease suppression in your patients with spondyloarthritis?
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Skin and Soft Tissue Infection 3029299 global 1 1.0 9 1.0 1.0 Journal Article 0 1
  Three Unusual Cases of Francisella tularensis-Related Prosthetic Joint Infection in France, and a Literature Review of 5 Cases
  Infectious Diseases2023-05-17 20:00:00
  A case series of Francisella tularensis-related prosthetic joint infection supports surgical treatment with long-term antibiotics.
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Rheumatoid Arthritis 83 global 1 0.25 9 0.25 2 0.25 0.25 Journal Article 0 1
  Prevalence and Characteristics of Arthritis Among Caregivers — 17 States, 2017 and 2019
  Rheumatology2023-04-02 20:00:00
  Clinicians can support caregivers with arthritis and their care recipients by promoting arthritis-related health interventions.
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Gout 39228 global 1 0.25 9 0.25 2 0.25 8 0.25 0.25 Clinical Brief 0 1
  What Factors Compound the Risk for Gout in Those Genetically Predisposed?
  Rheumatology2023-03-16 20:00:00
  Synergy noted between overweight and family history in new study.
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Psoriasis 29 global 1 0.75 9 0.75 2 0.75 0.75 Roundtable 0 1
  The Psoriasis Clinic: Maximizing Topical Treatment Options
  Dermatology2023-03-09 19:00:00
  Are you up to date on the latest topical therapies for psoriasis?
  
  0.75ABIM MOC 0.75CME/CE 45MIN

  
  Save
• Psoriasis 29 global 1 0.25 0.25 Clinical Case 0 1
  Full-Court Press: Talking to Patients About Psoriasis in Sensitive Areas
  Dermatology2023-03-09 19:00:00
  Did you know that almost half of patients with psoriasis lesions in their genital area do not discuss their symptoms with their clinician?
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• Spondylitis, Spondylosis, Kyphosis 118 us 1 0.75 9 0.75 0.75 Roundtable 0 1
  Optimizing Outcomes for Spondyloarthritis: Focus on Interleukin-23/-17 Inhibitors
  Rheumatology2023-03-08 19:00:00
  What's new in treatments for spondyloarthritis? Learn more about the rationale for novel therapies and the latest data.
  
  0.75ABIM MOC 0.75CME/CE 45MIN

  
  Save
• Obesity 3032356 global 1 0.25 9 0.25 2 0.25 3 0.25 8 0.25 0.25 Clinical Brief 0 1
  Could Obesity Affect the Response to Vitamin D Supplementation?
  Diabetes & Endocrinology2023-03-02 19:00:00
  Find out what new data reveal about the correlation between obesity and levels of serum total 25-hydroxyvitamin D (25-OHD).
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• COVID-19 Vaccine 6012767 global 1 0.25 9 0.25 2 0.25 3 0.25 8 0.25 0.25 Clinical Brief 0 1
  Can Vaccination Lower Risk for Long COVID for Patients With Rheumatic Disease?
  Rheumatology2023-01-19 19:00:00
  Future studies should examine how boosters, early treatment, immunomodulating drugs affect long COVID risk in rheumatic disease patients.
  
  0.25ABIM MOC 0.25CME/CE 15MIN

  
  Save
• 0 global 1 0.75 0.75 Commentary 0 1
  Fibrodysplasia Ossificans Progressiva: Expert Guidance on Diagnosis and Management
  Orthopaedics2023-01-03 19:00:00
  Did you know that misdiagnosis of this rare disease can be associated with serious iatrogenic harm?
  
  0.75ABIM MOC 0.75CME/CE 45MIN

  
  Save
• Social Determinants of Health 6010999 global 1 1.0 9 1.0 2 1.0 1.0 Clinical Case 0 1
  Elevating Rheumatic Disease Care: Case Challenges in Understanding and Addressing Health Disparities
  Rheumatology2022-12-27 19:00:00
  Did you know that social determinants of health could be worsening outcomes for some of your patients?
  
  1.0ABIM MOC 1.0CME/CE 60MIN

  
  Save
• Vasculitis 424 global 1 0.5 0.5 Roundtable 0 1
  The Balancing Act: A Clinical Conversation on Treating ANCA-Associated Vasculitis
  Infectious Diseases2022-12-26 19:00:00
  Substantial progress has been made in understanding and treating antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV). Join our experts as they walk us through a patient case.
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save
• Psoriasis 29 global 1 0.5 9 0.5 0.5 Clinical Review 0 1
  The Changing Landscape in Topical Therapies for Psoriasis
  Dermatology2022-12-20 19:00:00
  Did you know that there are new nonsteroidal topical options in psoriasis?
  
  0.5ABIM MOC 0.5CME/CE 30MIN

  
  Save

Education For Your Patient

• Click here for access to online educational resources to share with your patients and their care partners

Policies and Requirements

• CME Policies
• State CME Requirements